NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Doc,

As to the additional say 31. My opinion is that FDA told Linda that she could not continue enrolling patients to placebo as this would be unethical, however since there was a pool of already consented patients with tumor processing intitiated, these screened patients could still enroll as they had already committed prior to futility knowledge being available. It is not clear whether these 30ish were randomized or all,placed on DCVAX. That could have gone either way.

What I have become reasonably certain of is that we will win on PFS, may win on OS (cross-over throws a wrinkle into that time), and for absolute certainty milestone survival and long tail survival data will show incredible numbers. Mind-blowing really. And this point is certain TRUTH! Which only needs back of napkin stats to prove it.

My biggest regret is not buying to the direct sophisticated investor offering.

We are literally away from a life -saving theory for GbM which will launch us to MCR, renal cell, Liver and about a dozen other DCVAx-L targets.

Price prediction: short term=$6, mid term=$12, long term $84

MI Dendream